Publicacions en col·laboració amb investigadors/es de Tongji University (3)

2024

  1. Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial

    Lung Cancer, Vol. 189

2023

  1. Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

    New England Journal of Medicine, Vol. 389, Núm. 22, pp. 2039-2051

2019

  1. Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer

    Lung Cancer, Vol. 132, pp. 126-131